Biosup launches BioLabs.care to provide door-to-door diagnostic services. The brand has also launched top of the line PPE kits and forehead thermometers as part of its COVID-readiness drive.
Rapid and large-scale testing has been recognized as a crucial step towards combating the global COVID-19 crisis. This is especially true during the ongoing Unlock phase wherein citizens are stepping out once again in a bid to resume work. As instances of infection or simply the worry of infection might increase over the next few weeks, BioLabs.care will help healthcare professionals and the citizens of India to continue fighting and winning the battle against the deadly virus.
The customers can simply do their bookings at www.biolabs.care to avail the service. In the interest of the ‘Stay Home, Stay Safe’ directive, BioLabs.care’s door-to-door free sample collection services ensure the safe and hygienic collection from the comfort of your home. These samples will be collected under strict sanitization protocols by qualified and trained Phlebotomists equipped with disposable (single-use) Personal Protective Equipment (PPE) for highest-levels of protection. The actual test is conducted using the latest technologically-advanced equipment, with high-quality reagents, strict internal & external quality assessment, and control, backed by highly qualified professionals. Additionally, to ensure the privacy of the customers, the test results are classified and only shared within 36 hours to the registered email ID or phone number.
Speaking on the newly-launched service, the founding team said, “India’s battle against COVID-19 has been both impressive and exemplary over the past few months. Now, it’s time to double up on the combat-readiness. This is where BioLabs.care comes into the picture. With high-quality tests conducted across NABL and ICMR-accredited labs, we are helping the country expand its screening capabilities and further strengthen its fight against the pandemic. We encourage all symptomatic contacts of confirmed cases, symptomatic healthcare workers, asymptomatic high-risk contacts of confirmed cases, and other at-risk individuals to make the most of our affordable and reliable tests, and ensure their safety and India’s race towards becoming a COVID-free nation.”
While COVID-19 tests have been on the expensive side and, thus, inaccessible for vast socio-economic strata, BioLabs.care is conducting these tests at an opening offer price of 2,200 INR. For the utmost convenience of those who require the test, the company is offering free doorstep collection service with cash on delivery and prepaid payment options for the test. With an efficient network of government-approved labs and collection points in the major cities of India such as Delhi, Gurgaon, Manesar, Faridabad, Noida, Greater Noida, Sonipat, Kundli, Ghaziabad, etc., Biolabs.care will be present in more cities and states by September this year. On the back of its advanced value proposition, BioLabs.care is well on its way to becoming a benchmark in healthcare services by helping people and the healthcare officials in diagnosing the pandemic and finding quick solutions.
Biosup’s SITRA/DRDO Approved PPE kit: